These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 34052357)

  • 21. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
    Wang AY; Zhao J; Bieber B; Kanjanabuch T; Wilkie M; Marshall MR; Kawanishi H; Perl J; Davies S;
    Perit Dial Int; 2020 May; 40(3):310-319. PubMed ID: 32063209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.
    Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MW; Jones B; Kulkarni H; Langham R; Ranganathan D; Schollum J; Suranyi MG; Tan SH; Voss D;
    Perit Dial Int; 2012; 32(5):497-506. PubMed ID: 22991015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.
    Zurowska A; Feneberg R; Warady BA; Zimmering M; Monteverde M; Testa S; Calyskan S; Drozdz D; Salusky I; Kemper MJ; Ekim M; Verrina E; Misselwitz J; Schaefer F
    Am J Kidney Dis; 2008 Mar; 51(3):455-62. PubMed ID: 18295061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study.
    Thirugnanasambathan T; Hawley CM; Badve SV; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton P; Johnson DW
    Am J Kidney Dis; 2012 Jan; 59(1):84-91. PubMed ID: 21849228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
    Szeto CC; Chow KM; Leung CB; Wong TY; Wu AK; Wang AY; Lui SF; Li PK
    Kidney Int; 2001 Jun; 59(6):2309-15. PubMed ID: 11380835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.
    Ghali JR; Bannister KM; Brown FG; Rosman JB; Wiggins KJ; Johnson DW; McDonald SP
    Perit Dial Int; 2011; 31(6):651-62. PubMed ID: 21719685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
    Kavanagh D; Prescott GJ; Mactier RA
    Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal Dialysis-Associated Peritonitis Trends Using Medicare Claims Data, 2013-2017.
    Young EW; Zhao J; Pisoni RL; Piraino BM; Shen JI; Boudville N; Schreiber MJ; Teitelbaum I; Perl J; McCullough K
    Am J Kidney Dis; 2023 Feb; 81(2):179-189. PubMed ID: 36108889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center.
    Feng X; Yang X; Yi C; Guo Q; Mao H; Jiang Z; Li Z; Chen D; Cui Y; Yu X
    Perit Dial Int; 2014 May; 34(3):308-16. PubMed ID: 24497589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?
    Kan GW; Thomas MA; Heath CH
    Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003.
    Davenport A
    Perit Dial Int; 2009; 29(3):297-302. PubMed ID: 19458302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations, microbiology and outcomes of pre-training peritoneal dialysis-related peritonitis.
    Hayat A; Johnson DW; Hawley CM; Jaffrey LR; Mahmood U; Mon SSY; Cho Y
    Perit Dial Int; 2023 Mar; 43(2):173-181. PubMed ID: 35220814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Contributing to Peritonitis in Peritoneal Dialysis: Comparing Triple Cuff Saudi Catheter to Double Cuff Tenckhoff Catheter: A 12-Year Observational Study.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Hwiesh A; Taha A; Amir R; Al-Audah N; Abdel Galil MM; Nasr El-Din MA; Alhwiesh B; Alotaibi K; Fiore JR
    Saudi J Kidney Dis Transpl; 2021; 32(1):69-83. PubMed ID: 34145116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International peritoneal dialysis training practices and the risk of peritonitis.
    Cheetham MS; Zhao J; McCullough K; Fuller DS; Cho Y; Krishnasamy R; Boudville N; Figueiredo AE; Ito Y; Kanjanabuch T; Perl J; Piraino BM; Pisoni RL; Szeto CC; Teitelbaum I; Woodrow G; Johnson DW
    Nephrol Dial Transplant; 2022 Apr; 37(5):937-949. PubMed ID: 34634100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
    Blunden M; Zeitlin D; Ashman N; Fan SL
    Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverticular disease and treatment with gastric acid inhibitors do not predispose to peritonitis of enteric origin in peritoneal dialysis patients.
    del Peso G; Bajo MA; Gadola L; Millán I; Codoceo R; Celadilla O; Castro MJ; Aguilera A; Gil F; Selgas R
    Perit Dial Int; 2001; 21(4):360-4. PubMed ID: 11587398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis.
    Johnson DW; Clayton P; Cho Y; Badve SV; Hawley CM; McDonald S; Boudville N; Wiggins KJ; Bannister K; Brown F
    Perit Dial Int; 2012; 32(5):516-24. PubMed ID: 22302768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.